Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database ; volume:25 ; number:1 ; day:25 ; month:11 ; year:2024 ; pages:1-17 ; date:12.2024
The journal of headache and pain ; 25, Heft 1 (25.11.2024), 1-17, 12.2024
- Creator
-
Liu, Wen-Hui
Hu, Hui-Min
Li, Chen
Shi, Qing
Liu, Chun-Hua
Liu, An-Xiang
Li, Yi-Fan
Zhang, Yi
Mao, Peng
Fan, Bi-Fa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-024-01913-0
- URN
-
urn:nbn:de:101:1-2502102146547.644209168132
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Wen-Hui
- Hu, Hui-Min
- Li, Chen
- Shi, Qing
- Liu, Chun-Hua
- Liu, An-Xiang
- Li, Yi-Fan
- Zhang, Yi
- Mao, Peng
- Fan, Bi-Fa
- SpringerLink (Online service)
Other Objects (12)
Do immigrants attract FDI? District-level evidence from Germany
Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Possible adverse events of imidazole antifungal drugs during treatment of vulvovaginal candidiasis: analysis of the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
Do immigrants attract FDI? District-level evidence from Germany
Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Possible adverse events of imidazole antifungal drugs during treatment of vulvovaginal candidiasis: analysis of the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
Do immigrants attract FDI? District-level evidence from Germany
Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Possible adverse events of imidazole antifungal drugs during treatment of vulvovaginal candidiasis: analysis of the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database